combination drug
Scope
Date
~
-
Mergers & Acquisitions
SK becomes top shareholder of US contract drug maker CBM
SK Pharmteco Co., a South Korean contract development and manufacturing organization (CDMO), said on Wednesday it has secured management rights of t...
Sep 20, 2023 (Gmt+09:00)
-
Energy
Doosan Enerbility, KWP to advance power generation tech
South Korea's heavy industrial company Doosan Enerbility Co. and the government-owned Korea Western Power Co. (KWP) will jointly streamline domestic...
Sep 19, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong to develop eye drops for diabetic retinopathy
South Korea's Daewoong Pharmaceutical is venturing into the development of a product that can easily treat diabetic retinopathy in the form of ...
Sep 15, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Science joins race to develop Wegovy competitor
Hanmi Science Co., the holding company of South Korea’s pharmaceutical giant Hanmi Pharmaceutical Co., has joined the global race to develop t...
Sep 13, 2023 (Gmt+09:00)
-
Infrastructure
Shinhan, 3i, DWS to sell Dutch waste treatment firm to Ardian
South Korea’s Shinhan Asset Management Co., London-based 3i Group plc and Germany's DWS Group are set to sell their combined full stake in Dut...
Sep 13, 2023 (Gmt+09:00)
-
Bio & Pharma
AriBio to sell dementia drug AR1001 in China with partner
South Korea's clinical-stage biotech company AriBio Co. on Wednesday said it signed a memorandum of understanding on strategic cooperation with Chin...
Sep 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Wellmarker Bio signs worth of $528 mn tech transfer deal
Wellmarker Bio, South Korea's oncology drug development company, announced on Monday that it has signed a technology transfer agreement with a Europ...
Sep 12, 2023 (Gmt+09:00)
-
Bio & Pharma
AriBio applies for Phase 3 clinical trials in China for oral dementia drug
South Korean clinical-stage biotech company AriBio Co. on Thursday said it applied for Phase 3 clinical trials on the anti-Alzheimer's candidate t...
Sep 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong gets patent of Nabota as migraine drug in US
South Korea's Daewoong Pharmaceutical Co. announced on Thursday that it has received a patent from the US Patent and Trademark Office for the use of...
Sep 07, 2023 (Gmt+09:00)
-
Bio & Pharma
Yungjin Pharm's new drug candidate gets Fast Track from FDA
South Korea's Yungjin Pharm has secured Fast Track designation from the US Food and Drug Administration (FDA) for its new drug candidate KL1333, des...
Sep 06, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Boryung gets gov’t OK for diabetes drug Trubuddy
South Korea’s Boryung Corp. on Tuesday said it received approval from the Ministry of Food and Drug Safety for its new compound diabetes drug ...
Sep 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion to expand new plant for drug products
South Korean biopharmaceutical firm Celltrion Inc. announced on Tuesday that it plans to enlarge its finished pharmaceuticals manufacturing facility...
Sep 05, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N releases K-Cab in Singapore
South Korean bio-health company HK inno.N announced on Monday that it has released the new drug K-CAB for gastroesophageal reflux disease (GERD) in ...
Sep 04, 2023 (Gmt+09:00)
-
Metaverse
Netmarble, Hana Financial team up for metaverse service
South Korean game company Netmarble Corp. announced on Monday that it will partner with Hana Financial Group to develop new financial experiences an...
Sep 04, 2023 (Gmt+09:00)
-
Electric vehicles
Hyundai, LG to spend combined $7.6 bn to build EV, battery plants in US
Hyundai Motor Group and LG Energy Solution Ltd. will spend a combined $7.59 billion to build electric vehicle and battery cell plants in Georgia, th...
Sep 01, 2023 (Gmt+09:00)
-
Bio & Pharma
Discovery in S.Korea promises dieting without limits on eating
A drug candidate in South Korea could allow people seeking to lose weight to eat to their heart's content.The Center for Cognition and Sociality of ...
Sep 01, 2023 (Gmt+09:00)
-
Bio & Pharma
Voronoi to strengthen AI-driven open innovation
South Korea’s biotechnology startup Voronoi Inc. announced on Monday that it is intensifying its artificial intelligence (AI)-driven new drug ...
Aug 28, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma to participate in S.Korea’s new drug project
South Korea's JW Pharmaceutical announced on Monday that its experimental hair loss drug, JW0061, has been selected for a two-year funding program b...
Aug 28, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong applies for approval of Envlo in Saudi Arabia
South Korea's Daewoong Pharmaceutical Co. announced on Friday that it has submitted an application for regulatory approval of its new diabetes treat...
Aug 25, 2023 (Gmt+09:00)
-
Artificial intelligence
SK Telecom to enter generative AI market with large language model
SK Telecom announced on Wednesday that it will provide tailored generative AI services to businesses and public agencies using various advanced arti...
Aug 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm to start global clinical trials for immune-oncology drug
South Korea's Hanmi Pharmaceutical Co. announced on Tuesday that it has received approval for the phase 1 clinical trial plan of the immune-oncology...
Aug 22, 2023 (Gmt+09:00)
-
Automobiles
Kia’s first vehicles T-600, Brisa resurrected after 40 years
Not many people in the auto industry know that South Korea’s Kia Corp. started as a bicycle parts maker 79 years ago.Back in 1944, Kim Chul-ho...
Aug 21, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience to export $51 bn flu vaccine to Thailand
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, announced on Monday that it has signed a deal with Thailand's state-owned G...
Aug 21, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm to export epilepsy drug tech to Middle Eastern firm
South Korea's SK Biopharmaceuticals announced on Friday a strategic tie-up with Hikma MENA FZE, marking the introduction of its new epilepsy medicat...
Aug 18, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Qurient, US National Cancer Institute to develop anti-cancer drug
South Korea's Qurient Co. announced on Monday that it signed a research and development agreement with the US government agency National Cancer Inst...
Aug 14, 2023 (Gmt+09:00)
-
Pension funds
Blackstone, KKR join race for Korean pension fund's real estate debt
South Korea’s Government Employees Pension Service (GEPS) has shortlisted four global investment firms, Blackstone, KKR & Co., Goldman Sac...
Aug 11, 2023 (Gmt+09:00)
-
Bio & Pharma
ABL Bio gets OK for phase 1 clinical trials for immune-oncology drug
New drug development company ABL Bio Inc. announced on Thursday that it has received approval from the Ministry of Food and Drug Safety of South Kor...
Aug 10, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharmaceuticals forms Scientific Advisory Board
South Korea's SK Biopharmaceuticals assembled its Scientific Advisory Board (SAB) composed of world-renowned physicians and drug development experts...
Aug 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong launches GERD treatment Fexuclu in Philippines
South Korea's Daewoong Pharmaceutical announced on Tuesday that it has launched the GERD treatment drug "Fexuclue" (active ingredient: Fexuprazan) i...
Aug 01, 2023 (Gmt+09:00)
-
Electronics
LG’s front-load washer selected as best by Consumer Reports
LG Electronics Inc.'s front-load washers have seized the top four spots in the US consumer review conducted by Consumer Reports, earning the title o...
Aug 01, 2023 (Gmt+09:00)